MAFbx Antibodies

Santa Cruz Biotechnology features a diverse variety of MAFbx Antibodies for research in muscle atrophy and related pathways. MAFbx Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MAFbx, also known as Atrogin-1, is an E3 ubiquitin ligase that plays a critical role in the ubiquitin-proteasome pathway, mediating protein degradation in muscle cells. Its regulation is essential for maintaining muscle mass and function, particularly during periods of stress or inactivity. Understanding MAFbx function in muscle atrophy can provide insights into various muscle-wasting diseases and potential therapeutic targets. Researchers can investigate protein expression patterns in different muscle tissues and cellular compartments. Advanced visualization techniques enable detailed examination of MAFbx localization and interactions with other proteins. Multiple detection methods allow for comprehensive analysis of MAFbx expression levels and activity. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of muscle biology and developing new therapeutic strategies for muscle-wasting conditions.